A systematic review of the Tardieu Scale for the measurement of spasticity

被引:231
作者
Haugh, A. B.
Pandyan, A. D.
Johnson, G. R.
机构
[1] Univ Keele, Sch Hlth & Rehabil, Sheffield ST5 5NA, S Yorkshire, England
[2] Univ Keele, Inst Life Course Studies, Sheffield, S Yorkshire, England
[3] Newcastle Univ, CREST, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] Reg Neurol Rehabil Ctr, Newcastle Upon Tyne, Tyne & Wear, England
关键词
Tardieu scale; spasticity; validity; reliability; systematic review;
D O I
10.1080/09638280500404305
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Background. The Tardieu Scale has been suggested a more appropriate clinical measure of spasticity than the Ashworth or modified Ashworth Scales. It appears to adhere more closely to Lance's definition of spasticity as it involves assessment of resistance to passive movement at both slow and fast speeds. Objective. To review the available literature in which the Tardieu Scale has been used or discussed as a measure of spasticity, with a view to determining its validity and reliability. Study design. A systematic review of all literature found related to the Tardieu Scale ( keywords: Tardieu scale, spasticity) from Pubmed and Ovid databases, including medline, CINAHL, EMBASE, Journals at Ovid full text, EBM reviews and Cochrane database of systematic reviews. Hand searching was also used to track the source literature. Conclusions. In theory, we can acknowledge that the Tardieu Scale does, in fact, adhere more closely to Lance's definition of spasticity. However, there is a dearth of literature investigating validity and reliability of the scale. Some studies have identified the Tardieu Scale to be more sensitive than other measures, to change following treatment with botulinum toxin. Further studies need to be undertaken to clarify the validity and reliability of the scale for a variety of muscle groups in adult neurological patients.
引用
收藏
页码:899 / 907
页数:9
相关论文
共 30 条
[1]  
[Anonymous], 1969, REEDUCATION MORTRICE
[2]  
Barnes MP, 2001, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY, P1
[3]  
Booth Melissa Y, 2003, Pediatr Phys Ther, V15, P216, DOI 10.1097/01.PEP.0000096382.65499.E2
[4]   Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy [J].
Boyd, RN ;
Pliatsios, V ;
Starr, R ;
Wolfe, R ;
Graham, HK .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2000, 42 (01) :32-41
[5]  
Boyd RN, 2001, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY, P96
[6]   Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy [J].
Boyd, RN ;
Graham, HK .
EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 :S23-S35
[7]  
Boyd RN, 1998, DEV MED CHILD NEUROL, V40, P7
[8]   Soleus neurotomy for treatment of the spastic equinus foot [J].
Decq, P ;
Filipetti, P ;
Cubillos, A ;
Slavov, V ;
Lefaucheur, JP ;
Nguyen, JP .
NEUROSURGERY, 2000, 47 (05) :1154-1160
[9]  
Filipetti P, 2003, NEUROCHIRURGIE, V49, P226
[10]   Rehabilitation of spasticity and related problems in childhood cerebral palsy [J].
Flett, P .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2003, 39 (01) :6-14